Ketamine Assisted Psychotherapy
Ketamine assisted psychotherapy (KAP) is a therapeutic approach that combines the bio-medical benefits of ketamine with its psychedelic properties to facilitate a unique treatment process. This approach is supported by a growing body of research demonstrating the effectiveness of agents such as MDMA, psilocybin, and ketamine for the treatment of conditions such a depression, addiction, PTSD, chronic pain, and end of life distress. Ketamine is currently available for clinical use while MDMA and psilocybin are still progressing through the FDA approval process.
For an overview article about the effectiveness of KAP click here.
For my publications on psychedelic medicine click the links below:
Szuster, R.R. Asclepius Revisited: Ancient Myth and 21st Century Psychedelic Medicine. JAMA. (2022).